APA (7th ed.) Citation

Kurniawan, J., Handayu, A. D., Aprilicia, G., Bahri, D. R., & Hasan, I. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Interna Publishing.

Chicago Style (17th ed.) Citation

Kurniawan, Juferdy, Anugrah Dwi Handayu, Gita Aprilicia, Darlene Raudhatul Bahri, and Irsan Hasan. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Interna Publishing.

MLA (9th ed.) Citation

Kurniawan, Juferdy, et al. Resistance-Associated Substitutions (RAS) and Clinical Factors as Determinants of Sofosbuvir-Daclatasvir Treatment Outcomes in Chronic Hepatitis C Patients. Interna Publishing.